Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe SepsisSteven M. Opal, for the ACCESS Study Group, Marc Van Nuffelen et al.|JAMA|2013Cited by 797
Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic ShockPierre‐François Laterre, Derek C. Angus, Hans‐Christian Thorsen‐Meyer et al.|JAMA|2019Cited by 141
A multicenter, randomized, double-blind study of ulimorelin and metoclopramide in the treatment of critically ill patients with enteral feeding intolerance: PROMOTE trialDaren K. Heyland, Jesús González-Lama, Oscar Hoiting et al.|Intensive Care Medicine|2019Cited by 38
Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe SepsisSteven M. Opal, Daniel P. Rossignol, Derek C. Angus et al.|Unknown|2013Cited by 7